New York · 2025 Regular Session · Bill
S 493: Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 493 is a bill introduced in the New York Senate on January 8, 2025. According to its official title, it concerns: Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications. Primary sponsor: Nathalia Fernández (Democratic). It lists 1 additional sponsor. Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican/Conservative 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Nathalia Fernández | Primary sponsor | Democratic | Senate | 34 |
| George Borrello | Co-sponsor | Republican/Conservative | Senate | 57 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH
- REFERRED TO HEALTH